NEW YORK (GenomeWeb) - Nanosphere today announced after the close of the market that its first quarter revenues rose 76 percent on sales of its Verigene Gram Positive and Gram Negative Blood Culture Tests.

For the three months ended June 30, the Northbrook, Illinois-based molecular diagnostics company said it posted record-high revenues of $4.7 million, up from $2.7 million a year ago, beating the average Wall Street expectation of $4.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.